CCM
DAWN

Chicago Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Chicago Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$162K – 31
2026
Q1 		$162K Buy
+10,000
New +$141K 0.13% 28

Other funds holding DAWN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Chicago Capital Management's DAWN Position: Q2 2026 in Review

Chicago Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 10,000 shares — an estimated $162K sold.

Chicago Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $162K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Chicago Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Chicago Capital Management sold 10,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $162K.
  • Chicago Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Chicago Capital Management's Day One Biopharmaceuticals position peaked at $162K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Chicago Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.